{
    "2018-11-26": [
        [
            {
                "time": "",
                "original_text": "王老吉复兴，壮阳药爆发，13倍市盈率的白云山也许真的有利可图",
                "features": {
                    "keywords": [
                        "王老吉",
                        "壮阳药",
                        "白云山",
                        "市盈率"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "消费品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "白云山：全资子公司获得药品GMP证书",
                "features": {
                    "keywords": [
                        "白云山",
                        "全资子公司",
                        "药品GMP证书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}